INS and polycystic ovary syndrome: This population-based longitudinal study applied FDA to present novel insights into the dynamic patterns of IR by identifying distinct HOMA-IR and serum insulin concentration trajectories among women with PCOS, those meeting an isolated PCOS criterion, and healthy controls, stratified based on general or central obesity.